AVAILABLE MEDICINE FOR Alectinib Hydrochloride
There are no products to list.
Introduction to Alectinib Hydrochloride
Alectinib Hydrochloride is a targeted therapy that has transformed the landscape of treatment for non-small cell lung cancer (NSCLC) with specific genetic mutations. This innovative drug works by inhibiting anaplastic lymphoma kinase (ALK), blocking cancer cells from growing and multiplying, thereby offering hope to many patients facing advanced stages of this disease.
How it Works
By precisely targeting ALK proteins, Alectinib alters the signaling pathways that fuel tumor growth. Administered orally, it swiftly enters the bloodstream, allowing for systemic action against malignant cells while sparing most healthy tissues.
Side Effects and Precautions
While Alectinib offers significant benefits, potential side effects include fatigue, nausea, and liver enzyme elevation—each requiring careful monitoring. Patients should consult their healthcare provider regarding any pre-existing conditions or medications that may interact with Alectinib. Regular lab tests are essential to mitigate risks.
